07:00 , Mar 30, 2009 |  BioCentury  |  Finance

Ebb & Flow

With...
23:47 , Apr 4, 2008 |  BC Extra  |  Top Story

sanofi-aventis drops two Genfit compounds

sanofi-aventis (Euronext:SAN; NYSE:SNY) discontinued development of AVE8134 and AVE0847, which were developed with Genfit (Euronext:ALGFT) under a 1999 collaboration. AVE8134 is a peroxisome proliferation activated receptor (PPAR) alpha agonist, and AVE0847 is a PPAR alpha...
08:00 , Dec 10, 2007 |  BioCentury  |  Product Development

PPAR vigilance

PPAR vigilance...
07:00 , May 28, 2007 |  BioCentury  |  Politics, Policy & Law

Next up

Next up...